Company / Operating Income per Share
aTYR PHARMA INC Operating Income per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$0.92
FY2025
5-year range
-$2.09 / -$0.57
FY2021-FY2025
Trend
+13.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $-1.15 to $-0.92 over the past 2 years.
Based on SEC 10-K filings.
-0.92 in FY2025.
Improved from $-1.15 to $-0.92 over the past 2 years.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating income per share increased 13.9% year-over-year.
- Peak operating income per share was recorded in FY2022.
- Lowest operating income per share in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -6.50 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.92 | +13.9% |
| FY2024 | -$1.07 | +6.9% |
| FY2023 | -$1.15 | -101.4% |
| FY2022 | -$0.57 | +72.5% |
| FY2021 | -$2.09 | +75.3% |
| FY2020 | -$8.43 | +60.9% |
| FY2019 | -$21.56 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026